Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
12.10
-0.10 (-0.82%)
At close: May 18, 2026, 4:00 PM EDT
11.91
-0.19 (-1.57%)
After-hours: May 18, 2026, 6:14 PM EDT
Relay Therapeutics Stock Forecast
Stock Price Forecast
The 13 analysts that cover Relay Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $21, which forecasts a 73.55% increase in the stock price over the next year. The lowest target is $18 and the highest is $25.
Price Target: $21 (+73.55%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Relay Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 4 | 5 | 4 |
| Buy | 2 | 2 | 2 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 7 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $19 → $25 | Strong Buy | Maintains | $19 → $25 | +106.61% | Apr 29, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $13 → $22 | Strong Buy | Maintains | $13 → $22 | +81.82% | Apr 28, 2026 |
| Citizens | Citizens | Buy Maintains $17 → $19 | Buy | Maintains | $17 → $19 | +57.02% | Apr 28, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $17 → $21 | Buy | Maintains | $17 → $21 | +73.55% | Apr 28, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $14 → $18 | Buy | Maintains | $14 → $18 | +48.76% | Apr 28, 2026 |
Financial Forecast
Revenue This Year
8.72M
from 15.36M
Decreased by -43.24%
Revenue Next Year
15.58M
from 8.72M
Increased by 78.76%
EPS This Year
-1.56
from -1.61
EPS Next Year
-1.54
from -1.56
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 44.1M | 75.2M | ||||||
| Avg | 8.7M | 15.6M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 187.2% | 762.6% | ||||||
| Avg | -43.2% | 78.8% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.35 | -1.26 | ||||||
| Avg | -1.56 | -1.54 | ||||||
| Low | -1.92 | -2.11 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.